1. Stocks
    2. /
  2. Mesoblast Limited (ASX: MSB)
    3. /

Mesoblast Limited (ASX: MSB) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Mesoblast Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Mesoblast Limited (ASX: MSB)
    Latest News

    A happy couple looking at an iPad.
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    | James Mickleboro

    Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

    Read more »

    Doctor doing a telemedicine using laptop at a medical clinic
    Healthcare Shares

    Why is everyone talking about Mesoblast shares?

    | Bernd Struben

    ASX biotech share Mesoblast has been grabbing plenty of investor attention recently.

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Healthcare Shares

    Why the Mesoblast share price can rise another 60%

    | James Mickleboro

    The big gains may not be over according to Bell Potter.

    Read more »

    Woman in celebratory fist move looking at phone
    Broker Notes

    Brokers name 3 ASX shares to buy now

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Share Fallers

    Why Mesoblast, Regis Resources, Westgold, and WiseTech shares are sinking today

    | James Mickleboro

    These shares are having a tough time on Wednesday. What's going on?

    Read more »

    Worried ASX share investor looking at laptop screen
    Share Fallers

    Mesoblast share price dumps 10% as excitement simmers on FDA submission

    | Mitchell Lawler

    Investors are taking their feet off the gas as Mesoblast shares take a rest from their recent run.

    Read more »

    A man sees some good news on his phone and gives a little cheer.
    Share Gainers

    Why Austal, Mesoblast, Novonix, and Paladin Energy shares are racing higher

    | James Mickleboro

    These ASX shares are starting the week positively. But why?

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    Blast off! Mesoblast share price surging 60%

    | Bronwyn Allen

    Mesoblast shares are skyrocketing today.

    Read more »

    A businessman holding a butterfly net looks around hoping to snare a good ASX share investment
    Best Shares

    Top ASX shares to buy in April 2024

    | Motley Fool Staff

    Our Foolish writers are chock-full of stock ideas this month!

    Read more »

    A young women pumps her fists in excitement after seeing some good news on her laptop.
    Share Gainers

    Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

    | James Mickleboro

    These ASX shares are ending the week strongly. But why?

    Read more »

    A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
    Share Gainers

    3 ASX All Ords shares up 50%+ in March

    | James Mickleboro

    These ASX shares have been on fire this month. But why?

    Read more »

    Woman looks amazed and shocked as she looks at her laptop.
    Share Gainers

    Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

    | James Mickleboro

    These shares are having a good session on hump day. But why?

    Read more »

    Frequently Asked Questions

    No, Mesoblast does not pay shareholder dividends at this time.

    Yes, Mesoblast is listed on the ASX and the US Nasdaq under the ticker code NASDAQ: MESO.

    Mesoblast Ltd listed on the ASX on 16 December 2004.

    MSB ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Mesoblast Limited

    Mesoblast Ltd (ASX: MSB) is a clinical-stage biotechnology company. It develops and commercialises allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care.

    Its portfolio of Phase 3 product candidates includes its flagship remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD) as well as moderate to severe acute respiratory distress syndrome (ARDS). Its other candidates include REVASCOR® for advanced chronic heart failure and MPC-06-ID for chronic low back pain due to degenerative disc disease. These cell therapy candidates are towards the latter stages of their clinical trial pipelines. 

    Mesoblast has locations in Australia, the United States, and Singapore and is dual-listed on the ASX and the US Nasdaq (NASDAQ: MESO).

    Profile

    since

    Note